Novonesis, DK0060336014

Novonesis stock gains 0.49 percent ahead of the open

Published on 09/23/2026 at 02:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 21, 2026, Novonesis stock stood at DKK 430.50 on Nasdaq Copenhagen after a 0.49 percent gain. A DKK 1 billion buyback supported the session narrative.

Industrieanlage mit Fermentationstanks eines daenischen Biotech-Unternehmens
Fotorealistische Ansicht einer Biotech-Anlage von Novonesis (Novozymes), ISIN DK0060336014, mit modernen Fermentationstanks in Bagsvaerd, Illustration mit AI erstellt.

Novonesis stock closed at DKK 430.50 on Nasdaq Copenhagen on September 21, 2026, gaining 0.49 percent on the session. The stock moved higher as the company proceeded with a DKK 1 billion share buyback, according to Ad Hoc News.

September 21, 2026 in numbers

Novonesis A/S (ISIN DK0060336014) ended the September 21, 2026 session at DKK 430.50 on its primary Nasdaq Copenhagen listing. The 0.49 percent increase provided a quantified comparison with the prior close and followed the company buyback signal described in the dated market report.

The DKK 1 billion program was the specific capital-allocation development associated with the session. The same report also placed the average analyst target above the prevailing price, providing a second quantified comparison for the stock on September 21, 2026.

September 23, 2026 ahead of the open

The scheduled US session begins after publication, while the latest available Novonesis market figures remain the September 21, 2026 Nasdaq Copenhagen close. The buyback remains the dated company-related item framing the stock ahead of the open.

Disclaimer...

en | DK0060336014 | NOVONESIS | boerse | 70160804 | bgmi